{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:58Z","timestamp":1772165698404,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:00:00Z","timestamp":1732924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:00:00Z","timestamp":1732924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82205008"],"award-info":[{"award-number":["82205008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hangzhou Municipal Health Commission Project","award":["A20210083"],"award-info":[{"award-number":["A20210083"]}]},{"name":"Project of Zhejiang Provincial Administration of Traditional Chinese Medicine","award":["2023ZF137"],"award-info":[{"award-number":["2023ZF137"]}]},{"name":"Key Research Project of Zhejiang University of Traditional Chinese Medicine Affiliated Hospital","award":["2022FSYZZ14"],"award-info":[{"award-number":["2022FSYZZ14"]}]},{"name":"Zhejiang Provincial Department of Health Project","award":["2023RC242"],"award-info":[{"award-number":["2023RC242"]}]},{"name":"Zhejiang Provincial Public Welfare Fund Project","award":["LTGY23H270007"],"award-info":[{"award-number":["LTGY23H270007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-024-03880-9","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T22:39:06Z","timestamp":1732919946000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Relationship between IgM deposition in the mesangial region and the prognosis of IgA nephropathy: a single-centre retrospective study"],"prefix":"10.1186","volume":"25","author":[{"given":"Li","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongrong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengjie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,30]]},"reference":[{"issue":"3","key":"3880_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10157-021-02154-0","volume":"26","author":"Q Jia","year":"2022","unstructured":"Jia Q, Ma F, Yang X, Li L, Liu C, Sun R, Li R, Sun S. Long-term outcomes of IgA nephropathy patients with less than 25% crescents and mild proteinuria. Clin Exp Nephrol. 2022;26(3):257\u201365. https:\/\/doi.org\/10.1007\/s10157-021-02154-0.","journal-title":"Clin Exp Nephrol"},{"key":"3880_CR2","doi-asserted-by":"publisher","unstructured":"\u0218tefan G, Nicoleta S. Sec\u0103reanu Silviu., Popa Otilia., Capusa Cristina.(2022). Immunosuppressive therapy versus supportive care in IgA nephropathy patients with stage 3 and 4 chronic kidney disease. Medicine (Baltimore), 101(36), e30422. https:\/\/doi.org\/10.1097\/MD.0000000000030422","DOI":"10.1097\/MD.0000000000030422"},{"issue":"3","key":"3880_CR3","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s11255-022-03286-2","volume":"55","author":"X Tang","year":"2023","unstructured":"Tang X, Wen Q, Zhou Q, Yang Q, Chen W, Yu X. Prognostic significance of the extent of tubulointerstitial lesions in patients with IgA nephropathy. Int Urol Nephrol. 2023;55(3):671\u20137. https:\/\/doi.org\/10.1007\/s11255-022-03286-2.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"3880_CR4","doi-asserted-by":"publisher","first-page":"11151","DOI":"10.1038\/s41598-020-68087-y","volume":"10","author":"T Moriyama","year":"2020","unstructured":"Moriyama T, Karasawa K, Miyabe Y, Akiyama K, Ogura S, Takabe T, Sugiura N, Seki M, Iwabuchi Y, Uchida K, Nitta K. Validation of the revised Oxford classification for IgA nephropathy considering treatment with corticosteroids\/immunosuppressors. Sci Rep. 2020;10(1):11151. https:\/\/doi.org\/10.1038\/s41598-020-68087-y.","journal-title":"Sci Rep"},{"key":"3880_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-023-03685-z","author":"N Saleem","year":"2023","unstructured":"Saleem N, Nasir H, Anwar F, Aziz M, Khurshid K, Bashir S, Khan A. To evaluate the utility of Oxford classification in predicting renal outcome in IgA nephropathy patients. Int Urol Nephrol. 2023. https:\/\/doi.org\/10.1007\/s11255-023-03685-z. Advance online publication.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"3880_CR6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12882-019-1420-0","volume":"20","author":"TD Bi","year":"2019","unstructured":"Bi TD, Zheng JN, Zhang JX, Yang LS, Liu N, Yao L, Liu LL. Serum complement C4 is an important prognostic factor for IgA nephropathy: a retrospective study. BMC Nephrol. 2019;20(1):244. https:\/\/doi.org\/10.1186\/s12882-019-1420-0.","journal-title":"BMC Nephrol"},{"issue":"7","key":"3880_CR7","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1681\/ASN.2014101000","volume":"26","author":"N Maillard","year":"2015","unstructured":"Maillard N, Wyatt RJ, Julian BA, Kiryluk K, Gharavi A, Fremeaux-Bacchi V, Novak J. Current understanding of the role of complement in IgA Nephropathy. J Am Soc Nephrology: JASN. 2015;26(7):1503\u201312. https:\/\/doi.org\/10.1681\/ASN.2014101000.","journal-title":"J Am Soc Nephrology: JASN"},{"key":"3880_CR8","doi-asserted-by":"publisher","first-page":"110354","DOI":"10.1016\/j.intimp.2023.110354","volume":"120","author":"S Wang","year":"2023","unstructured":"Wang S, Dong L, Qin A, Tan J, Zhou X, Qin W. Roles of mesangial C3 and C1q deposition in the clinical manifestations and prognosis of IgAN. Int Immunopharmacol. 2023;120:110354. https:\/\/doi.org\/10.1016\/j.intimp.2023.110354.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"3880_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12882-021-02237-w","volume":"22","author":"L Wu","year":"2021","unstructured":"Wu L, Liu D, Xia M, Chen G, Liu Y, Zhu X, Liu H. Immunofluorescence deposits in the mesangial area and glomerular capillary loops did not affect the prognosis of immunoglobulin a nephropathy except C1q:a single-center retrospective study. BMC Nephrol. 2021;22(1):43. https:\/\/doi.org\/10.1186\/s12882-021-02237-w.","journal-title":"BMC Nephrol"},{"issue":"2","key":"3880_CR10","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s40620-022-01363-4","volume":"36","author":"M Xie","year":"2023","unstructured":"Xie M, Zhu Y, Wang X, Ren J, Guo H, Huang B, Wang S, Wang P, Liu Y, Liu Y, Zhang J. Predictive prognostic value of glomerular C3 deposition in IgA nephropathy. J Nephrol. 2023;36(2):495\u2013505. https:\/\/doi.org\/10.1007\/s40620-022-01363-4.","journal-title":"J Nephrol"},{"issue":"6","key":"3880_CR11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMp1716193","volume":"378","author":"G Bakris","year":"2018","unstructured":"Bakris G, Sorrentino M. Redefining hypertension - assessing the New blood-pressure guidelines. N Engl J Med. 2018;378(6):497\u20139. https:\/\/doi.org\/10.1056\/NEJMp1716193.","journal-title":"N Engl J Med"},{"key":"3880_CR12","doi-asserted-by":"publisher","unstructured":"Levey A, de Jong P, Coresh J, El Nahas M, Astor B, Matsushita K, Gansevoort R, Kasiske B, Eckardt K. (2011) The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 80(1):17\u201328. https:\/\/doi.org\/10.1038\/ki.2010.483","DOI":"10.1038\/ki.2010.483"},{"key":"3880_CR13","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.3892\/etm.2018.7050","volume":"17","author":"Y Hao","year":"2019","unstructured":"Hao Y, Zhao Y, Huang R, Fu P. Analysis of the relationship between Oxford classification,IgM deposition and multiple indexes and the adverseprognosis of patients with primary IgA nephropathy and related risk factors. Experimental Therapeutic Med. 2019;17:1234\u20139. https:\/\/doi.org\/10.3892\/etm.2018.7050.","journal-title":"Experimental Therapeutic Med"},{"issue":"3","key":"3880_CR14","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11255-020-02651-3","volume":"53","author":"D Chang","year":"2021","unstructured":"Chang D, Cheng Y, Luo R, Zhang C, Zuo M, Xu Y, Dai W, Li Y, Han M, He X, Ge S, Xu G. The prognostic value of platelet-to-lymphocyte ratio on the long-term renal survival in patients with IgA nephropathy. Int Urol Nephrol. 2021;53(3):523\u201330. https:\/\/doi.org\/10.1007\/s11255-020-02651-3.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"3880_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10157-016-1251-2","volume":"21","author":"H Kikuchi","year":"2017","unstructured":"Kikuchi H, Kanda E, Mandai S, Akazawa M, Iimori S, Oi K, Naito S, Noda Y, Toda T, Tamura T, Sasaki S, Sohara E, Okado T, Rai T, Uchida S. Combination of low body mass index and serum albumin level is associated with chronic kidney disease progression: the chronic kidney disease-research of outcomes in treatment and epidemiology (CKD-ROUTE) study. Clin Exp Nephrol. 2017;21(1):55\u201362. https:\/\/doi.org\/10.1007\/s10157-016-1251-2.","journal-title":"Clin Exp Nephrol"},{"issue":"9","key":"3880_CR16","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1007\/s11255-022-03140-5","volume":"54","author":"H Song","year":"2022","unstructured":"Song H, Wei C, Hu H, Wan Q. Association of the serum albumin level with prognosis in chronic kidney disease patients. Int Urol Nephrol. 2022;54(9):2421\u201331. https:\/\/doi.org\/10.1007\/s11255-022-03140-5.","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"3880_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s11255-016-1453-2","volume":"49","author":"M Shao","year":"2017","unstructured":"Shao M, Wang S, Parameswaran PK. Hypoalbuminemia: a risk factor for acute kidney injury development and progression to chronic kidney disease in critically ill patients. Int Urol Nephrol. 2017;49(2):295\u2013302. https:\/\/doi.org\/10.1007\/s11255-016-1453-2.","journal-title":"Int Urol Nephrol"},{"issue":"23","key":"3880_CR18","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1056\/NEJMoa1415463","volume":"373","author":"T Rauen","year":"2015","unstructured":"Rauen T, Eitner F, Fitzner C, Sommerer C, Zeier M, Otte B, Panzer U, Peters H, Benck U, Mertens PR, Kuhlmann U, Witzke O, Gross O, Vielhauer V, Mann JF, Hilgers RD, Floege J. Intensive supportive care plus Immunosuppression in IgA Nephropathy. N Engl J Med. 2015;373(23):2225\u201336. https:\/\/doi.org\/10.1056\/NEJMoa1415463. & STOP-IgAN Investigators","journal-title":"N Engl J Med"},{"key":"3880_CR19","doi-asserted-by":"publisher","unstructured":"Lv, J., Wong, M. G., Hladunewich, M. A., Jha, V., Hooi, L. S., Monaghan, H., Zhao,M., Barbour, S., Jardine, M. J., Reich, H. N., Cattran, D., Glassock, R., Levin, A.,Wheeler, D. C., Woodward, M., Billot, L., Stepien, S., Rogers, K., Chan, T. M., Liu,Z. H., TESTING Study Group (2022). Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial. JAMA, 327(19), 1888\u20131898. https:\/\/doi.org\/10.1001\/jama.2022.5368","DOI":"10.1001\/jama.2022.5368"},{"issue":"4","key":"3880_CR20","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s10238-021-00703-1","volume":"21","author":"L Tan","year":"2021","unstructured":"Tan L, Tang Y, Pei GQ, Zhong ZX, Tan JX, Ma Y, Wang DG, Zhou L, Sheikh-Hamad D, Qin W. Mesangial IgM deposition predicts renal outcome in patients with IgA nephropathy: a multicenter, observational study. Clin Experimental Med. 2021;21(4):599\u2013610. https:\/\/doi.org\/10.1007\/s10238-021-00703-1.","journal-title":"Clin Experimental Med"},{"issue":"8","key":"3880_CR21","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/pin.12442","volume":"66","author":"G \u015etefan","year":"2016","unstructured":"\u015etefan G, Ismail G, Stancu S, Zugravu A, Andronesi A, Mandache E, Mircescu G. Validation study of Oxford classification of IgA Nephropathy: the significance of extracapillary hypercellularity and mesangial IgG immunostaining. Pathol Int. 2016;66(8):453\u20139. https:\/\/doi.org\/10.1111\/pin.12442.","journal-title":"Pathol Int"},{"issue":"1","key":"3880_CR22","doi-asserted-by":"publisher","first-page":"2313179","DOI":"10.1080\/0886022X.2024.2313179","volume":"46","author":"G Stefan","year":"2024","unstructured":"Stefan G, Stancu S, Zugravu A, Terinte-Balcan G. Prognostic role of mesangial IgM deposition in IgA nephropathy: a long-term cohort study. Ren Fail. 2024;46(1):2313179. https:\/\/doi.org\/10.1080\/0886022X.2024.2313179.","journal-title":"Ren Fail"},{"issue":"2","key":"3880_CR23","doi-asserted-by":"publisher","first-page":"2386146","DOI":"10.1080\/0886022X.2024.2386146","volume":"46","author":"Z Huang","year":"2024","unstructured":"Huang Z, Xu J, Ma J, Yuan C, Su Q, Chu Y, Huang J, Bian X. Clinical significance of glomerular IgM deposit in IgA nephropathy: a 5-year follow-up study. Ren Fail. 2024;46(2):2386146. https:\/\/doi.org\/10.1080\/0886022X.2024.2386146.","journal-title":"Ren Fail"},{"issue":"1","key":"3880_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12865-021-00467-z","volume":"22","author":"F Wang","year":"2021","unstructured":"Wang F, Yu J, Zhang L, Zhang Y, Zhang J, Liu B, Yang X. Clinical relevance of glomerular IgM deposition in patients with lupus nephritis. BMC Immunol. 2021;22(1):75. https:\/\/doi.org\/10.1186\/s12865-021-00467-z.","journal-title":"BMC Immunol"},{"issue":"1","key":"3880_CR25","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1080\/07853890.2021.1897664","volume":"53","author":"F Yu","year":"2021","unstructured":"Yu F, Zhu X, Yuan S, Chen X, Li Z, Qu Z, Liu H, Sun L, Liu F. Predictive value of sub classification of focal segmental glomerular sclerosis in Oxford classification of IgA nephropathy. Ann Med. 2021;53(1):587\u201395. https:\/\/doi.org\/10.1080\/07853890.2021.1897664.","journal-title":"Ann Med"},{"issue":"3","key":"3880_CR26","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s10157-018-1651-6","volume":"23","author":"C Heybeli","year":"2019","unstructured":"Heybeli C, Oktan MA, Y\u0131ld\u0131z S, Arda H\u00dc, \u00dcnl\u00fc M, \u00c7avdar C, Sifil A, \u00c7elik A, Sar\u0131o\u011flu S, \u00c7amsar\u0131 T. Clinical significance of mesangial IgM deposition in patients with IgA nephropathy. Clin Exp Nephrol. 2019;23(3):371\u20139. https:\/\/doi.org\/10.1007\/s10157-018-1651-6.","journal-title":"Clin Exp Nephrol"},{"issue":"6","key":"3880_CR27","first-page":"324","volume":"70","author":"Z Liu","year":"1990","unstructured":"Liu Z, Li L. Significance of IgM deposition in IgA nephropathy: An appraisal based on renal re-biopsy. Zhonghua Yi Xue Za Zhi. 1990;70(6):324\u20136.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"3880_CR28","doi-asserted-by":"publisher","first-page":"7045630","DOI":"10.1155\/2017\/7045630","volume":"2017","author":"C Auriti","year":"2017","unstructured":"Auriti C, Prencipe G, Moriondo M, Bersani I, Bertaina C, Mond\u00ec V, Inglese R. Mannose-binding lectin: biologic characteristics and role in the susceptibility to infections and ischemia-reperfusion related Injury in critically ill neonates. J Immunol Res. 2017;2017:7045630. https:\/\/doi.org\/10.1155\/2017\/7045630.","journal-title":"J Immunol Res"},{"issue":"2","key":"3880_CR29","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.kint.2023.04.029","volume":"104","author":"J Barratt","year":"2023","unstructured":"Barratt J, Lafayette RA, Zhang H, Tesar V, Rovin BH, Tumlin JA, Reich HN, Floege J. IgA nephropathy: the lectin pathway and implications for targeted therapy. Kidney Int. 2023;104(2):254\u201364. https:\/\/doi.org\/10.1016\/j.kint.2023.04.029.","journal-title":"Kidney Int"},{"key":"3880_CR30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.humpath.2017.10.012","volume":"71","author":"IE Lloyd","year":"2018","unstructured":"Lloyd IE, Ahmed F, Revelo MP, Khalighi MA. De novo immune complex deposition in kidney allografts: a series of 32 patients. Hum Pathol. 2018;71:109\u201316. https:\/\/doi.org\/10.1016\/j.humpath.2017.10.012.","journal-title":"Hum Pathol"},{"issue":"9","key":"3880_CR31","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.2215\/CJN.01190216","volume":"11","author":"YM Zhang","year":"2016","unstructured":"Zhang YM, Gu QH, Huang J, Qu Z, Wang X, Meng LQ, Wang F, Liu G, Cui Z, Zhao MH. Clinical significance of IgM and C3 glomerular deposition in primary focal segmental glomerulosclerosis. Clin J Am Soc Nephrology: CJASN. 2016;11(9):1582\u20139. https:\/\/doi.org\/10.2215\/CJN.01190216.","journal-title":"Clin J Am Soc Nephrology: CJASN"},{"issue":"3","key":"3880_CR32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10238-021-00768-y","volume":"22","author":"X Yu-Zhu","year":"2022","unstructured":"Yu-Zhu X, Na-Ya H, Ya-Gui Q, Xiong-Hui C, Zhi-Jian L, Wei C, Xin W. Clinical characteristics and outcomes of idiopathic membranous nephropathy with glomerular IgM deposits. Clin Experimental Med. 2022;22(3):455\u201364. https:\/\/doi.org\/10.1007\/s10238-021-00768-y.","journal-title":"Clin Experimental Med"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03880-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03880-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03880-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T11:02:43Z","timestamp":1732964563000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03880-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,30]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3880"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03880-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4898300\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,30]]},"assertion":[{"value":"12 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Research Ethics Committee of Hangzhou Hospital of Traditional Chinese Medicine and exempted participants from signing informed consent.(ethics number: 2021KY045).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"438"}}